Exelixis (EXEL) - Stock price history

Stock price history of Exelixis from 2000 to 2025

Annual Stock Price Performance

Year	Performance
2025	30.52%
2024	39.16%
2023	47.18%
2022	-16.37%
2021	-10.96%
2020	13.65%
2019	-11.59%
2018	-37.36%
2017	106.38%
2016	171.58%
2015	241.82%
2014	-76.70%
2013	26.92%
2012	-1.93%
2011	-44.24%
2010	9.47%
2009	41.19%
2008	-42.56%
2007	-8.87%
2006	-7.60%
2005	2.39%
2004	35.71%
2003	-7.24%
2002	-49.40%
2001	31.00%
2000	-0.85%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
GlaxoSmithKline GSK	A$73.49	0.66%	🇬🇧 UK
Sanofi SNY	A$72.84	0.40%	🇫🇷 France
Merck MRK	A$152.84	0.40%	🇺🇸 USA
Bristol-Myers Squibb BMY	A$81.93	1.61%	🇺🇸 USA
Amgen AMGN	A$494.97	0.91%	🇺🇸 USA
Johnson & Johnson JNJ	A$312.01	-0.93%	🇺🇸 USA
Pfizer PFE	A$38.08	0.60%	🇺🇸 USA
Curis CRIS	A$1.62	-6.96%	🇺🇸 USA
AVEO Oncology AVEO	A$22.68	0.00%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Exelixis (EXEL)